Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management. (Q37886997)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657842 AND SRC:MED&resulttype=core&format=json

3 February 2020

review article

1 reference

title

Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657842 AND SRC:MED&resulttype=core&format=json

3 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657842 AND SRC:MED&resulttype=core&format=json

3 February 2020

John Andrew Carlson

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657842 AND SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Konstantinos Linos

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657842 AND SRC:MED&resulttype=core&format=json

3 February 2020

Jeffrey S Ross

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657842 AND SRC:MED&resulttype=core&format=json

3 February 2020

publication date

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657842 AND SRC:MED&resulttype=core&format=json

3 February 2020

published in

Biomarkers in Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657842 AND SRC:MED&resulttype=core&format=json

3 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657842 AND SRC:MED&resulttype=core&format=json

3 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657842 AND SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

333-360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657842 AND SRC:MED&resulttype=core&format=json

3 February 2020

cites work

Cancer statistics, 2009

1 reference

New techniques in dermatopathology that help to diagnose and prognosticate melanoma.

21 January 2018

1 reference

The Melanoma Epidemic: Res Ipsa Loquitur

21 January 2018

1 reference

Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data

21 January 2018

1 reference

Management of metastatic melanoma

21 January 2018

1 reference

The current epidemiology of cutaneous malignant melanoma

21 January 2018

1 reference

Biomarkers in melanoma: predisposition, screening and diagnosis

21 January 2018

1 reference

The epidemiology of UV induced skin cancer

21 January 2018

1 reference

Somatic activation of KIT in distinct subtypes of melanoma

21 January 2018

1 reference

Distinct sets of genetic alterations in melanoma

21 January 2018

1 reference

BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site

21 January 2018

1 reference

A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women

21 January 2018

1 reference

Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma

21 January 2018

1 reference

Histopathology of solar lentigines of the face: a quantitative study.

21 January 2018

1 reference

Grading of atypia in nevi: correlation with melanoma risk

21 January 2018

1 reference

Non-melanoma skin cancer.

21 January 2018

1 reference

Human melanocyte biology, toxicology, and pathology

21 January 2018

1 reference

Vulvar malignant melanoma associated with human papillomavirus DNA: report of two cases and review of literature.

21 January 2018

1 reference

Epidermodysplasia verruciformis and cutaneous human papillomavirus DNA, but not genital human papillomavirus DNAs, are frequently detected in vulvar and vaginal melanoma

21 January 2018

1 reference

Spatial density of primary malignant melanoma in sun-shielded body sites: A potential guide to melanoma genesis

21 January 2018

1 reference

Growth rate as a prognostic factor in localized invasive cutaneous melanoma.

21 January 2018

1 reference

Melanoma thickness trends in the United States, 1988-2006.

21 January 2018

1 reference

Melanoma epidemic: a midsummer night's dream?

21 January 2018

1 reference

Genetics: what advice for patients who present with a family history of melanoma?

21 January 2018

1 reference

The prevention, diagnosis, referral and management of melanoma of the skin: concise guidelines.

21 January 2018

1 reference

Errors in cancer diagnosis: current understanding and future directions

21 January 2018

1 reference

Model predicting survival in stage I melanoma based on tumor progression

21 January 2018

1 reference

Molecular diagnostics in melanoma.

21 January 2018

1 reference

Biomarkers in melanoma: staging, prognosis and detection of early metastases.

21 January 2018

1 reference

Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit

21 January 2018

1 reference

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

21 January 2018

1 reference

Metastatic pathways and time courses in the orderly progression of cutaneous melanoma

21 January 2018

1 reference

Systemic chemotherapy for the treatment of metastatic melanoma

21 January 2018

1 reference

Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?

21 January 2018

1 reference

Biomarkers in melanoma: stage III and IV disease.

21 January 2018

1 reference

Targeted therapy for melanoma: a primer

21 January 2018

1 reference

Mutator phenotype in cancer: timing and perspectives

21 January 2018

1 reference

21 January 2018

The Hallmarks of Cancer

1 reference

Tumor progression: a brief historical perspective

21 January 2018

1 reference

Genomic instability--an evolving hallmark of cancer

21 January 2018

1 reference

Microsatellite instability and its relevance to cutaneous tumorigenesis

21 January 2018

1 reference

Genetic instability and darwinian selection in tumours

21 January 2018

1 reference

Epigenetic field for cancerization

21 January 2018

1 reference

Genetic instabilities in human cancers

21 January 2018

1 reference

Can chromosomal instability initiate tumorigenesis?

21 January 2018

1 reference

A comprehensive catalogue of somatic mutations from a human cancer genome

21 January 2018

1 reference

A small-cell lung cancer genome with complex signatures of tobacco exposure

21 January 2018

1 reference

Cancers exhibit a mutator phenotype: clinical implications

21 January 2018

1 reference

Cell selection as driving force in lung and colon carcinogenesis

21 January 2018

1 reference

Accumulation of driver and passenger mutations during tumor progression

21 January 2018

1 reference

Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture

21 January 2018

1 reference

Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis.

21 January 2018

1 reference

Chromosome 17 aneusomy detected by fluorescence in situ hybridization in vulvar squamous cell carcinomas and synchronous vulvar skin

21 January 2018

1 reference

Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression

21 January 2018

1 reference

The age distribution of cancer and a multi-stage theory of carcinogenesis

21 January 2018

1 reference

Cytogenetic alterations in nonmelanoma skin cancer: a review

21 January 2018

1 reference

Non-melanoma skin cancer: what drives tumor development and progression?

21 January 2018

1 reference

Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects.

21 January 2018

1 reference

RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis

21 January 2018

1 reference

Melanoma stem cells: the dark seed of melanoma

21 January 2018

1 reference

Cancer stem cells and differentiation therapy

21 January 2018

1 reference

Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression

21 January 2018

1 reference

Cytogenetics of melanoma and nonmelanoma skin cancer

21 January 2018

1 reference

Morphological and immunophenotypic variations in malignant melanoma

21 January 2018

1 reference

Tutorial on melanocytic lesions.

21 January 2018

1 reference

Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center

21 January 2018

1 reference

Malignant melanoma: a review of 75 malpractice cases

21 January 2018

1 reference

Pitfalls in the diagnosis of malignant melanoma: findings of a risk management panel study

21 January 2018

1 reference

Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions

21 January 2018

1 reference

Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008.

21 January 2018

1 reference

The Spitzoid lesion: rethinking Spitz tumors, atypical variants, 'Spitzoid melanoma' and risk assessment

21 January 2018

1 reference

Reliability of the histopathologic diagnosis of malignant melanoma in childhood.

21 January 2018

1 reference

Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions.

21 January 2018

1 reference

Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting

21 January 2018

1 reference

The approach to the patient with a difficult melanocytic lesion

21 January 2018

1 reference

Molecular genetics of melanocytic neoplasia: practical applications for diagnosis

21 January 2018

1 reference

Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool

21 January 2018

1 reference

Progress in melanoma histopathology and diagnosis

21 January 2018

1 reference

The use and application of special techniques in assessing melanocytic tumours

21 January 2018

1 reference

Failure of senescence in the dysplasia-melanoma sequence: demonstration using a tissue microarray and a revised paradigm for melanoma

21 January 2018

1 reference

Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma

21 January 2018

1 reference

RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi.

21 January 2018

1 reference

The influence of immunohistochemistry on mRNA recovery from microdissected frozen and formalin-fixed, paraffin-embedded sections

21 January 2018

1 reference

Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours

21 January 2018

1 reference

Molecular diagnostics-an emerging frontier in dermatopathology.

21 January 2018

1 reference

Noninvasive genomic detection of melanoma

21 January 2018

1 reference

Immunohistochemical characteristics of melanoma

21 January 2018

1 reference

Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.

21 January 2018

1 reference

Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues

21 January 2018

1 reference

Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays

21 January 2018

1 reference

Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.

21 January 2018

1 reference

Immunohistochemical markers of melanocytic lesions: a review of their diagnostic usefulness

21 January 2018

1 reference

Melanin pigmentation in mammalian skin and its hormonal regulation

21 January 2018

1 reference

Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations

21 January 2018

1 reference

Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity

21 January 2018

1 reference

Prognostic value of serial blood S100B determinations in stage IIB–III melanoma patients: A corollary study to EORTC trial 18952

21 January 2018

1 reference

Statistical analysis of the concordance of immunohistochemical stains with the final diagnosis in spitzoid neoplasms

21 January 2018

1 reference

Melanocytes in long-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain

21 January 2018

1 reference

Expression of vitamin D receptor decreases during progression of pigmented skin lesions.

21 January 2018

1 reference

The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms

21 January 2018

1 reference

WT1 as a complementary marker of malignant melanoma: an immunohistochemical study of whole sections

21 January 2018

1 reference

A multi-marker assay to distinguish malignant melanomas from benign nevi

21 January 2018

1 reference

Worms gang up on bacteria

21 January 2018

1 reference

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

21 January 2018

1 reference

p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma

21 January 2018

1 reference

Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. A quantitative immunohistochemical study

21 January 2018

1 reference

Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors

21 January 2018

1 reference

Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway

21 January 2018

1 reference

Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas

21 January 2018

1 reference

Loss of heterozygosity analysis of cutaneous melanoma and benign melanocytic nevi: laser capture microdissection demonstrates clonal genetic changes in acquired nevocellular nevi

21 January 2018

1 reference

Classifying Melanocytic Tumors Based on DNA Copy Number Changes

21 January 2018

1 reference

Neonatal giant congenital nevi with proliferative nodules: a clinicopathologic study and literature review of neonatal melanoma

21 January 2018

1 reference

Melanoma pathology: important issues for clinicians involved in the multidisciplinary care of melanoma patients

21 January 2018

1 reference

Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization

21 January 2018

1 reference

Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma

21 January 2018

1 reference

Superficial melanocytic neoplasms with pagetoid melanocytosis: a study of interobserver concordance and correlation with FISH.

21 January 2018

1 reference

Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes

21 January 2018

1 reference

Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi

21 January 2018

1 reference

Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases

21 January 2018

1 reference

Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up.

21 January 2018

1 reference

Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis

21 January 2018

1 reference

Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma

21 January 2018

1 reference

Copy Number Gains in 11q13 and 8q34 Are Highly Linked to Prognosis in Cutaneous Malignant Melanoma

21 January 2018

1 reference

Staging and prognosis of cutaneous melanoma

21 January 2018

1 reference

Final version of 2009 AJCC melanoma staging and classification

21 January 2018

1 reference

Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009.

21 January 2018

1 reference

Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas

21 January 2018

1 reference

Molecular characterization of minimal residual cancer cells in patients with solid tumors

21 January 2018

1 reference

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

21 January 2018

1 reference

Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.

21 January 2018

1 reference

Sentinel Lymph Node Biopsy for Melanoma: Critical Assessment at its Twentieth Anniversary

21 January 2018

1 reference

Prognostic usefulness of sentinel lymph node biopsy for patients who have clinically node negative, localized, primary invasive cutaneous melanoma: a Bayesian analysis using informative published reports

21 January 2018

1 reference

Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.

21 January 2018

1 reference

Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma

21 January 2018

1 reference

Stage migration after minor changes in histologic estimation of tumor burden in sentinel lymph nodes: the protocol trap.

21 January 2018

1 reference

Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.

21 January 2018

1 reference

Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.

21 January 2018

1 reference

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

21 January 2018

1 reference

Sentinel-node biopsy or nodal observation in melanoma

21 January 2018

1 reference

Analysis of predictive factors for the outcome of complete lymph node dissection in melanoma patients with metastatic sentinel lymph nodes

21 January 2018

1 reference

Is There a Need for Axillary Dissection in Breast Cancer?

21 January 2018

1 reference

Improving melanoma classification by integrating genetic and morphologic features

21 January 2018

1 reference

Genetic and morphologic features for melanoma classification

21 January 2018

1 reference

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

21 January 2018

1 reference

Melanoma prognostic model using tissue microarrays and genetic algorithms

21 January 2018

1 reference

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.

21 January 2018

1 reference

Prognostic significance of allelic losses in primary melanoma

21 January 2018

1 reference

BRAF alterations are associated with complex mutational profiles in malignant melanoma

21 January 2018

1 reference

Chromosome territories, nuclear architecture and gene regulation in mammalian cells

21 January 2018

1 reference

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases

21 January 2018

1 reference

The natural course of cutaneous melanoma

21 January 2018

1 reference

Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma

21 January 2018

1 reference

Determinants of survival in patients with brain metastases from cutaneous melanoma

21 January 2018

1 reference

Randomized dose-escalation study evaluating peginterferon alfa-2a in patients with metastatic malignant melanoma

21 January 2018

1 reference

Cancer. Addiction to oncogenes--the Achilles heal of cancer

21 January 2018

1 reference

21 January 2018

1 reference

Novel inhibitors in the treatment of metastatic melanoma

21 January 2018

1 reference

New approaches in metastatic melanoma: biological and molecular targeted therapies

21 January 2018

1 reference

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants

21 January 2018

1 reference

Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization

21 January 2018

1 reference

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma

21 January 2018

1 reference

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

21 January 2018

1 reference

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

21 January 2018

1 reference

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

21 January 2018

1 reference

BRAF gene amplification can promote acquired resistance to MEK inhibitors in cancer cells harboring the BRAF V600E mutation

21 January 2018

1 reference

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

21 January 2018

1 reference

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

21 January 2018

1 reference

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

21 January 2018

1 reference

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.

21 January 2018

1 reference

Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma

21 January 2018

1 reference

Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets

21 January 2018

1 reference

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

PTEN signaling pathways in melanoma

21 January 2018

1 reference

Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.

21 January 2018

1 reference

The PI3K pathway as drug target in human cancer

21 January 2018

1 reference

CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium

21 January 2018

1 reference

AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity

21 January 2018

1 reference

Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors

21 January 2018

1 reference

KIT gene mutations and copy number in melanoma subtypes

21 January 2018

1 reference

Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics

21 January 2018

1 reference

Major response to imatinib mesylate in KIT-mutated melanoma.

21 January 2018

1 reference

Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates

21 January 2018

1 reference

Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib

21 January 2018

1 reference

A phase 2 trial of dasatinib in advanced melanoma

21 January 2018

1 reference

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi

21 January 2018

1 reference

Oncogenic mutations in GNAQ occur early in uveal melanoma

21 January 2018

1 reference

Mutations in GNA11 in uveal melanoma

21 January 2018

1 reference

Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade

21 January 2018

1 reference

Phase I/II study of ipilimumab for patients with metastatic melanoma

21 January 2018

1 reference

Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4

21 January 2018

1 reference

Ipilimumab: attenuation of an inhibitory immune checkpoint improves survival in metastatic melanoma

21 January 2018

1 reference

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group

21 January 2018

1 reference

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

21 January 2018

1 reference

Sun Exposure, Phenotypic Characteristics, and Cutaneous Malignant Melanoma. An Analysis According to Different Clinico-Pathological Variants and Anatomic Locations (Italy)

21 January 2018

1 reference

A natural history of melanomas and dysplastic nevi

21 January 2018

1 reference

Defining fast-growing melanomas

21 January 2018

1 reference

Phase I/II trial of tremelimumab in patients with metastatic melanoma

21 January 2018

1 reference